UBS Group’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.93M Buy
464,207
+167,762
+57% +$681K ﹤0.01% 5009
2025
Q4
$1.92M Sell
296,445
-202,591
-41% -$1.26M ﹤0.01% 5018
2025
Q3
$2.79M Buy
499,036
+137,772
+38% +$596K ﹤0.01% 4649
2025
Q2
$1.2M Buy
361,264
+46,935
+15% +$135K ﹤0.01% 5287
2025
Q1
$912K Sell
314,329
-106,234
-25% -$322K ﹤0.01% 5360
2024
Q4
$1.5M Buy
420,563
+329,874
+364% +$1.52M ﹤0.01% 4985
2024
Q3
$452K Buy
90,689
+63,651
+235% +$248K ﹤0.01% 5301
2024
Q2
$70.3K Buy
27,038
+25,038
+1,252% +$83.6K ﹤0.01% 6426
2024
Q1
$8.52K Sell
2,000
-290
-13% -$965 ﹤0.01% 7327
2023
Q4
$4.63K Buy
+2,290
New +$4.05K ﹤0.01% 7841
2023
Q2
Sell
-3,744
Closed -$4.27K 8871
2023
Q1
$4.27K Buy
+3,744
New +$3.25K ﹤0.01% 8210
2022
Q4
Sell
-9,068
Closed -$11K 10705
2022
Q3
$11K Buy
9,068
+8,653
+2,085% +$9.78K ﹤0.01% 8272
2022
Q2
$0 Sell
415
-414
-50% -$551 ﹤0.01% 10276
2022
Q1
$2K Sell
829
-1,130
-58% -$3.3K ﹤0.01% 9602
2021
Q4
$8K Sell
1,959
-8,041
-80% -$40.4K ﹤0.01% 9013
2021
Q3
$44K Sell
10,000
-4,060
-29% -$15.9K ﹤0.01% 6431
2021
Q2
$56K Sell
14,060
-114
-0.8% -$455 ﹤0.01% 6324
2021
Q1
$74K Sell
14,174
-9,595
-40% -$51K ﹤0.01% 6191
2020
Q4
$128K Buy
23,769
+9,669
+69% +$57.9K ﹤0.01% 5526
2020
Q3
$68K Sell
14,100
-23,981
-63% -$157K ﹤0.01% 5426
2020
Q2
$185K Buy
38,081
+18,893
+98% +$87K ﹤0.01% 4856
2020
Q1
$42K Buy
19,188
+9,188
+92% +$34.9K ﹤0.01% 5963
2019
Q4
$58K Hold
10,000
﹤0.01% 6264
2019
Q3
$32K Hold
10,000
﹤0.01% 6446
2019
Q2
$42K Sell
10,000
-3,322
-25% -$17K ﹤0.01% 6062
2019
Q1
$92K Buy
+13,322
New +$93.3K ﹤0.01% 5127
2018
Q4
Sell
-1,325
Closed -$23K 8007
2018
Q3
$23K Buy
+1,325
New +$21.8K ﹤0.01% 6717

Other funds holding AQST